NL-OMON35791已完成不适用
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours. - Biomarkers for Angiogenesis in Renal Cell Carcinoma and NET.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age 18 years or older
- •2. Patients with clear cell renal cell carcinoma with metastases or patients with a low-grade neuro-endocrine tumor with metastases
- •3. Written informed consent
排除标准
- •1. Use of L-dopa or SSRI
- •2. Patients with a second primary malignancy
研究者
相似试验
已完成
不适用
Biomarkers in patients with renal cell carcinomaRenal cell carcinomaCancerISRCTN57274668Cambridge University Hospitals NHS Foundation Trust80
尚未招募
不适用
Analysis of angiogenesis markers, circulating tumour, endothelial progenitor, endothelial, dendritic, T and B cells in women receiving adjuvant chemotherapy for early breast cancerCancer - BreastBreast CancerACTRN12605000732684Mater Adult hospital50
招募中
不适用
Biomarkers of Renal CancerTumor, SolidAngiomyolipomaRenal Cell CarcinomaOncocytomaNCT05785052Biorek S.R.L.1,000
已完成
不适用
Novel Prognostic Markers in Renal CancerRenal Cell CarcinomaNCT01002937Royal Marsden NHS Foundation Trust182
尚未招募
不适用
Imaging and urine biomarkers for renal tumor assessment.C64Malignant neoplasm of kidney, except renal pelvisrenal tumorDRKS00029264Department of Diagnostic and Interventional Radiology, University Medical Center Goettingen905